Emerging Biomarkers in Alcoholic Liver Disease

Posted: April 14, 2022

It’s Not Just Support. It’s Solutions.

diapharma bioassays hemostasis thrombosis chromogenic

Non-Invasive Biomarkers for Alcoholic Liver Disease Studies

Biomarkers of cell death and regeneration, inflammation, and immune response become useful tools as new potential Alcoholic Liver Disease (ALD) and Alcoholic Hepatitis (AH) treatment options are investigated. Serum biomarkers can provide valuable insights into:

  • Disease severity and progression in ALD and AH research studies
  • Mechanisms involved in ALD and AH pathogenesis

 

ALD AH Research K18 OPN sCD163 C3a C5b-9 C5a ELISA Assay Test Kit

DiaPharma has the tools for ALD Research.

Measure hepatocyte apoptosis and/or necrosis with our Cytokeratin 18/Keratin 18 (CK18/K18) biomarkers:

Additional Biomarkers of Interest:

  • Osteopontin (OPN)
  • Soluble CD163 (sCD163)
  • Complement Factors 3a/5a/C5b-9

Visit diapharma.com for our comprehensive portfolio including biomarkers for Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH) and Drug Induced Liver Injury (DILI).

All products are for research use only in the U.S. and Canada. Not for use in diagnostic procedures.

 

liver disease research Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI)

diapharma

liver disease research Nonalcoholic Fatty Liver Disease (NAFLD) / Nonalcoholic Steatohepatitis (NASH), Alcoholic Hepatitis (AH), Drug Induced Liver Injury (DILI)

It’s Not Just Support. It’s Solutions.

Celebrating 25 years of scientific expertise, with support just a call or click away.

diapharma hemostasis assays

diapharma

DiaPharma Group, Inc. 8948 Beckett Rd, West Chester, OH 45069

Technical Support: 1.800.447.3846

ML-00-00894Rev01